 |
|
Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis
Chia-Ling Yu, Fu-Chi Yang, Szu-Nian Yang, Ping-Tao Tseng, Brendon Stubbs, Ta-Chuan Yeh, Chih-Wei Hsu, Dian-Jeng Li, Chih-Sung Liang
Psychiatry Investig. 2021;18(10):958-967. Published online 2021 Oct 8 DOI: https://doi.org/10.30773/pi.2021.0209
|
|
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow, Rachel Yehuda
Current Neuropharmacology.2024; 22(4): 636. CrossRef Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)
Kenneth Shinozuka, Burton J. Tabaac, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir
American Journal of Therapeutics.2024; 31(2): e141. CrossRef Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin
Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir
American Journal of Therapeutics.2024; 31(2): e121. CrossRef Methyl transfer in psilocybin biosynthesis
Jesse Hudspeth, Kai Rogge, Sebastian Dörner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten
Nature Communications.2024;[Epub] CrossRef Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, Andrew Holmes
Neuropharmacology.2023; 226: 109418. CrossRef Are psychedelics the answer to chronic pain: A review of current literature
Nina I. Kooijman, Tim Willegers, Anke Reuser, Wim M. Mulleners, Cornelis Kramers, Kris C. P. Vissers, Selina E. I. van der Wal
Pain Practice.2023; 23(4): 447. CrossRef The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
Daniel A Kinderlehrer
International Medical Case Reports Journal.2023; Volume 16: 109. CrossRef The need for establishing best practices and gold standards in psychedelic medicine
Allison Feduccia, Gabby Agin-Liebes, Collin M. Price, Nicole Grinsell, Summer Paradise, David M. Rabin
Journal of Affective Disorders.2023; 332: 47. CrossRef Psilocybin in Palliative Care: An Update
Emily Whinkin, Moira Opalka, Conor Watters, Atara Jaffe, Sunil Aggarwal
Current Geriatrics Reports.2023; 12(2): 50. CrossRef Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred, Ole Jakob Storebø
Journal of Psychopharmacology.2023; 37(7): 649. CrossRef Psilocybin Use in Palliative Care #464
Mark D. Sims, John M. Hendrick
Journal of Palliative Medicine.2023; 26(9): 1287. CrossRef Expectancies for Subjective and Antidepressant Effects in Psilocybin Users
Mitch Earleywine, Maha N. Mian, Joseph A. De Leo
Journal of Humanistic Psychology.2023;[Epub] CrossRef
|